The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.

Baluchnejadmojarad, Tourandokht

The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling. [electronic resource] - Experimental gerontology 12 2017 - 70-76 p. digital

Publication Type: Journal Article

1873-6815

10.1016/j.exger.2017.10.023 doi


Animals
Apoptosis--genetics
Brain--pathology
Calcium-Calmodulin-Dependent Protein Kinase Type 2--metabolism
Corpus Striatum--metabolism
Cyclic AMP Response Element-Binding Protein--metabolism
Cyclic AMP-Dependent Protein Kinases--metabolism
Disease Models, Animal
Dopaminergic Neurons--drug effects
Glucuronidase--pharmacology
Klotho Proteins
Male
Neuroprotective Agents--pharmacology
Oxidative Stress--drug effects
Oxidopamine
Parkinson Disease--drug therapy
Rats
Rats, Wistar
Reactive Oxygen Species--metabolism
Signal Transduction--drug effects
Substantia Nigra--drug effects
Tyrosine 3-Monooxygenase--metabolism